develop our anticancer therapeutic candidates
EX-10.35B 48 w07623exv10w35b.htm EX-10.35B exv10w35b
Exhibit 10.35B
AMENDMENT TO IRREVOCABLE LETTER OF CREDIT
ISSUING BANK: | NUMBER | ||||||
MANUFACTURERS AND TRADERS TRUST CO. | IRREVOCABLE TRANSFERABLE | SB ###-###-#### | |||||
25 SOUTH CHARLES STREET | STANDBY | ||||||
15TH FLOOR | LETTER OF CREDIT | Amendment | |||||
BALTIMORE, MD 21201 | Number 1 | ||||||
DATE OF ISSUE: | DATE OF THIS AMENDMENT : | ||||||
2003 APRIL 9 | 2004 APRIL 1 | ||||||
APPLICANT : | [BENEFICIARY: Before this amendment) | ||||||
AVALON PHARMACEUTICALS, INC. | M AND T BANK, AS TRUSTEE | ||||||
20358 GOLDENROD LANE | CORPORATE TRUST DEPT, | ||||||
GERMANTOWN, MD | 25 SOUTH CHARLES STREET | ||||||
20876 | BALTIMORE, MD 21201 | ||||||
ADVISING BANK: (Ref:) | |||||||
This amendment is to be considered as part of the above mentioned credit, and must be attached thereto. | |||||||
Ladies and Gentlemen:
We hereby amend our letter of credit as follows:
(1) The aggregate amount of the credit before any drawing is changed as follows:
The amount is decreased by USDl, 219,726.00
The aggregate amount of the credit before any drawings is now USD10,977,534.00.
EFFECTIVE IMMEDIATELY THE STATED AMOUNT OF THE LETTER OF CREDIT IS $10,977,534.00, OF WHICH STATED AMOUNT $10,800,000.00 REPRESENTS THE PRINCIPAL PORTION AND $177,534.00 REPRESENTS THE INTEREST PORTION.
All other terms and conditions remain unchanged.
Should you have any questions, please do not hesitate to contact us at 410 ###-###-####.
Thank you for the opportunity to be of service to you.
/s/ [ILLEGIBLE] | ||
Authorized Signature |